insights_auto
Nega EVGN tushdi 4,09%?
Batafsil oʻrganishchevron_right
EVGN:NASDAQ
Evogene Ltd
0,38 US$
arrow_downward
-4,09%(-0,016) 1K
9-okt, 16:00:00 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoEVGN tikeri uchun statistika yaratilmoqda...
Ochish
0,39 US$
Yuqori
0,39 US$
Past
0,37 US$
Bozor kapitali
6,90 mln
Oʻrtacha hajm
2,57 mln
Hajmi
106,04 ming
52 haftalik eng yuqori
1,49 US$
52 haftalik eng past
0,35 US$
Aksiya boʻyicha daromad
-0,90 US$
Beta
1,44
Muomaladagi aksiyalar
18,05 mln
Xodimlar soni
52
Ochish
0,39 US$
Yuqori
0,39 US$
Past
0,37 US$
Bozor kapitali
6,90 mln
Oʻrtacha hajm
2,57 mln
Hajmi
106,04 ming
52 haftalik eng yuqori
1,49 US$
52 haftalik eng past
0,35 US$
Aksiya boʻyicha daromad
-0,90 US$
Beta
1,44
Muomaladagi aksiyalar
18,05 mln
Xodimlar soni
52
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Investing.com Nigeria
·
1 soat oldin
Form 13D/A Evogene Ltd. For: 11 October By Investing.com
Profil
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs.
In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
Evogene Ltd haqida